Survival of bifidobacteria in adult intestinal tract

Folia Microbiologica

Volumn 55, Issue 3, 2010, Pages 281-285

  Grmanova M ^a   Vlkova E ^a   Rada, V ^a   Homutova I ^a  

^a CZECH UNIVERSITY OF LIFE SCIENCES PRAGUE   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT;

ADULT; ARTICLE; BACTERIAL COUNT; BIFIDOBACTERIUM; GASTROINTESTINAL TRACT; HUMAN; HUMAN EXPERIMENT; MICROBIAL VIABILITY; MICROBIOLOGY; MIDDLE AGED; PHYSIOLOGY;

ADULT; BIFIDOBACTERIUM; COLONY COUNT, MICROBIAL; GASTROINTESTINAL TRACT; HUMAN EXPERIMENTATION; HUMANS; MICROBIAL VIABILITY; MIDDLE AGED; PROBIOTICS;

BACTERIA (MICROORGANISMS);

EID: 77953452476     PISSN: 00155632     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12223-010-0042-5     Document Type: Article

References (23)

1. Benno Y., Mitsouka T.: Impact of Bifidobacterium longum on human fecal microflora. Microbiol. Immunol. 36, 683-694 (1992).
2. Bezkorovainy A.: Probiotics: determinants of survival and growth in the gut. Am. J. Clin. Nutr. 2, 399-405 (2001).
3. Bouhnik Y., Pochart P., Marteau P., Arlet G., Godere I., Rambaud J. C.: Fecal recovery in humans of viable Bifidobacterium sp. ingested in fermented milk. Gastroenterology 102, 875-878 (1992).
4. Brigidi P., Vitali B., Swennen E., Altomare L., Rossi M., Matteuzzi D.: Specific detection of Bifidobacterium strains in a pharmaceutical probiotic product and in human feces by PCR. Syst. Appl. Microbiol. 3, 391-399 (2000).
5. Collins J. K., Thoron G., O'sullivan G.: Selection of probiotic strains for human applications. Internat. Dairy J. 8, 487-490 (1998).
6. Fujiwara S., Seto Y., Kimura A., Hashiba H.: Intestinal transit of an orally administered streptomycin-rifampicin-resistant variant of Bifidobacterium longum SBT2928: its long-term survival and effect on the intestinal microflora and metabolism. J. Appl. Microbiol. 90, 43-52 (2001).
7. Fuller R.: Probiotics in human medicine. Gut32, 439-442 (1991).
8. Kailasapathy K., Chin J.: Survival and therapeutic potential of probiotic organisms with reference to Lactobacillus acidophilus and Bifidobacterium spp. Immunol. Cell. Biol. 78, 80-88 (2000).
9. Kopečný J., Mrázek J., Fliegerová K., Frühauf P., Tučková L.: The intestinal microflora of childhood patients with indicated celiac disease. Folia Microbiol. 53, 214-216 (2008).
10. Křížová J., Španová A., Rittich B.: RAPD and rep-PCR fingerprinting for characterization of Bifidobacterium species. Folia Microbiol. 53, 99-104 (2008).
11. Kullen M. J., Amman M. M., O'shaughnessy W., O'sullivan D. J., Busta F. F., Brady U.: Differentiation of ingested bifidobacteria by DNA fingerprinting demonstrates the survival of an unmodified strain in the gastrointestinal tract of humans. J. Nutr. 127, 89-94 (1997).
12. Langhendries J. P., Detry J., van Hees J., Lamboray J. M., Darimont J., Mozin M. J., Secretin M. C., Senterre J.: Effects of a fermented infant formula containing viable bifidobacteria on the fecal flora composition and pH of healthy full-term infants. J. Pediatr. Gastroenterol. Nutr. 21, 177-181 (1995).
13. Matsuki T., Watanabe K., Tanaka R., Fukuda M., Oyaizu H.: Distribution of bifidobacterial species in human intestinal microflora examined with 16S rRNA-gene-targeted species-specific primers. Appl. Environ. Microbiol. 65, 4506-4512 (1999).
14. Palacios M. C., Haros M., Rosell C. M., Sanz Y.: Selection of phytate-degrading human bifidobacteria and application in whole wheat dough fermentation. Food Microbiol. 25, 169-176 (2008).
15. Pochart P., Marteau P., Bouhnik Y., Godere I., Bourlioux P., Rambaund J. C.: Survival of bifidobacteria ingested via fermented milk during their passage through the human small intestine: an in vivo study using intestinal perfusion. Am. J. Clin. Nutr. 55, 78-80 (1992).
16. Rada V., Petr J.: A new selective medium for the isolation of glucose non-fermenting bifidobacteria from hen caeca. J. Microbiol. Meth. 43, 127-132 (2000).
17. Saarela M., Hallamaa K., Mattila-Sandholm T., Mättö J.: The effect of lactose derivatives lactulose, lactitol and lactobionic acid on the functional and technological properties of potentially probiotic Lactobacillus strains. Internat. Dairy J. 13, 291-302 (2003).
18. Salminen S., Lahtinen S., Gueirnonde M.: Probiotics and the reduction in risk of disease. Austral. J. Dairy Technol. 60, 99-103 (2005).
19. Stanton C., Gardiner G., Lynch P. B., Collins J. K., Fitzgerald G., Ross R. P.: Probiotic cheese. Internat. Dairy J. 8, 491-496 (1998).
20. Tannock G. W.: Normal Microflora. An Introduction to Microbes Inhabiting the Human Body. Chapman and Hall, London 1995.
21. Vlková E., Rada V., Šmehilová M., Killer J.: Auto-aggregation and co-aggregation ability in bifidobacteria and clostridia. Folia Microbiol. 53, 263-269 (2008).
22. Wang R., Cao W. W., Cerniglia C. E.: PCR detection and quantitation of predominant anaerobic bacteria in human and animal fecal samples. Appl. Environ. Microbiol. 62, 1242-1247 (1996).
23. Yuki N., Watanabe K., Mike A., Tagami Y., Tanaka R., Ohwaki M., Morotomi M.: Survival of a probiotic, Lactobacillus casei strain Shirota, in the gastrointestinal tract: selective isolation from feces and identification using monoclonal antibodies. Internat. J. Food Microbiol. 48, 51-57 (1999).